the aid library

LIST OPTIONS

Filter

517

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (254)

View PDF (410)

Ziele für nachhaltige Entwicklung

Renn.Nord Regionale Netzstellen Nachhaltigkeitsstrategie (2019) C1

Die 169 Unterziele im Einzelnen

Download (10607)

View PDF (3626)

Internal Medicine Clinical treatment guidelines

Ministry of Health, Rwanda (2012)

Download (5088)

View PDF (1435)

Pediatrics Clinical treatment guidelines

Ministry of Health, Rwanda (2012)

External Link

Mетодические рекомендации - Oсобенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (Covid-19) у детей Версия 2 (03.07.2020)
recommended

Александрович Ю.С., Алексеева Е.И., Бакрадзе М.Д., et al. Министерство здравоохранения Российской Федерации (2020) C2

Oсобенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (Covid-19) у детей (clinical guidelines pediatrics)

Download (1016)

View PDF (1105)

Guinea : Reference Map of Kankan Region (as of 02 Janv 2015)

UN Mission for Ebola Emergency Response (2015)

Download (1553)

View PDF (2836)

Hatua za kwanza zinazotakiwa kuchukua kwenye mlipuko mkali wa magonjwa ya kuhara

World Health Organization (2010) C_WHO

The document provides guidelines for the prevention and control of cholera outbreaks. It focuses on key strategies such as improving access to safe drinking water, ensuring proper sanitation, and promoting hygiene practices to prevent the spread of the disease. The guidelines also emphasize the impo... more

Download (296)

View PDF (536)

Die Umsetzung der globalen 2030 - Agenda für nachhaltige Entwicklung inklusiv gestalten

VENRO Verband Entwicklungspolitik und nachhaltige Entwicklung (2016) CC

In diesem gemeinsamen Forderungspapier formulieren der Deutsche Behindertenrat (DBR) und der Verband Entwicklungspolitik und Humanitäre Hilfe (VENRO)1 Anforderungen an die Fortschreibung der Nationalen Nachhaltigkeitsstrategie im Hinblick auf die Inklusion von Menschen mit Behinderungen

Download (504)

View PDF (1375)

Rapid Case Management Form. Ebola Virus Disease, 16 May 2018.

World Health Organization WHO (2018) C_WHO

Download (133)

View PDF (216)

The Guide for Training Community Health Workers

Ministry of Health, Community Development, Gender, Elderly and Children, Government City - Mtumba (2021) CC2

For many years, Community Health Care Workers (CHWs) in Tanzania and Africa in general have played significant role in community health promotion. Their specific roles have been changing from time to time. However, their key roles have over time included giving health education and dissemination of ... more

Download (286)

View PDF (255)

Technical specifications for Pressure Swing Adsorption(PSA) Oxygen Plants
recommended

World Health Organization WHO (2020) C_WHO

Oxygen is an essential medicine required at all levels of the health care system; only high quality, medical-grade oxygen should be given to patients. Pressure swing adsorption (PSA) oxygen generating plants are a source of medical-grade oxygen. This document provides technical specifications as th... more

Download (211)

View PDF (257)

Poremećaji koji se javljaju kao posljedica traume i posttraumatski stresni poremećaj (PTSP)

Ethno-Medizinisches Zentrum e. V. (2015) C1

Ovaj vodič treba da pruži opšte/opće informacije o ovim oboljenjima, takozvanim „poremećajima koji se javljaju kao posljedica traume“ i naročito o „posttraumatskom stresnom poremećaju“ (PTSP). Osim toga, on treba da pomogne u traženju mogućnosti liječenja i savjetovanja.

Download (887)

View PDF (1464)

National guidelines for the use of pediatric antiretroviral therapy in Cambodia

National Center for HIVAIDS, Dermatology and STD, Cambodia Ministry of Health (2011) CC

External Link

Cleaning and Decontamination of Ebola on Surfaces

OSHA Occupational Safety and Health Administration (2014)

Download (181)

View PDF (349)

Overview of Mtoto Mwerevu Stunting Reduction Toolkit, Swahili Version

IMA World Health (2021) CC

The Mtoto Mwerevu Stunting Reduction Toolkit is a resource for government and organisations involved in addressing stunting and broader nutrition issues in Tanzania. The toolkit was developed in conjunction with the Government of Tanzania (GoT) with funding from UK Aid as part of the Addressing Stun... more

Download (301)

View PDF (214)

COVID-19 Treatment Guidelines

National Department of Health, South Africa (2022) CC

Updated Treatment Guidelines

Download (278)

View PDF (292)

WHO pharmaceuticals newsletter - No. 1, 2023

World Health Organisation (WHO) (2023) C_WHO

The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world. In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f... more

Download (305)

View PDF (308)

Dokumentation der 12. Fachtagung (Ver)störende Kinder Traumatisierte Kinder und Jugendliche als Herausforderung im pädagogischen Alltag

Netzwerk - Wiener Netzwerk gegen sexuelle Gewalt an Mädchen, Buben und Jugendlichen (2014) C1

Inhaltsangabe: Vorwort; Trauma bei Kindern und JugendlichenTraumatisierte Kinder im pädagogischen; Sekundäre Traumatisierung des Helfer_innensystems – Der Versuch zu verstehen und ein Pläydoyer für Enttabuisierung und Prävention; Trauma und Traumafolgen im Kindesalter; Zusammenarbeit mit E... more

Download (1076)

View PDF (1063)

GEMÄSS - CBRN-Gefahrenlagen: Leitfaden für Rettungs- und Einsatzdienste bei Ereignissen mit chemischen, biologischen Gefahrstoffen, mit radioaktiven Stoffen und ionisierender Strahlung
recommended

Johanniter-Unfall-Hilfe e.V. (2010) C2

Leitfaden für Rettungs- und Einsatzdienste bei Ereignissen mit chemischen, biologischen Gefahrstoffen, mit radioaktiven Stoffen und ionisierender Strahlung

Download (145)

View PDF (263)

Case Report Form for suspected cases of multisystem inflammatory syndrome (MIS) in children and adolescents temporally related to COVID-19

World Health Organization WHO (2020) C_WHO

Global COVID-19 Clinical Platform: Case Record Form for suspected cases of Multisystem inflammatory syndrome (MIS) in children and adolescents temporally related to COVID-19

Technical specifications for Pressure Swing Adsorption(PSA) Oxygen Plants recommended

GEMÄSS - CBRN-Gefahrenlagen: Leitfaden für Rettungs- und Einsatzdienste bei Ereignissen mit chemischen, biologischen Gefahrstoffen, mit radioaktiven Stoffen und ionisierender Strahlung recommended

Technical specifications for Pressure Swing Adsorption(PSA) Oxygen Plants
recommended

GEMÄSS - CBRN-Gefahrenlagen: Leitfaden für Rettungs- und Einsatzdienste bei Ereignissen mit chemischen, biologischen Gefahrstoffen, mit radioaktiven Stoffen und ionisierender Strahlung
recommended